Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-26

Clinical Trial Update: Ibuprofen as a Possible Preventer of Post Bronchoscopy Fever [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ibuprofen to prevent fever after bronchoscopy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Post Bronchoscopy Fever | Phase 2 | Status: COMPLETED